Location History:
- Corvallis, OR (US) (2011 - 2012)
- San Anselmo, CA (US) (2012)
- Kirkland, WA (US) (2017 - 2019)
- Fallbrook, CA (US) (2021 - 2023)
Company Filing History:
5 out of 33 
2 out of 10 
1 out of 10 Years Active: 2011-2023
Title: The Innovative Mind of Stephen B. Shrewsbury
Introduction
Stephen B. Shrewsbury, a prominent inventor based in Fallbrook, California, has made significant contributions to the field of pharmaceutical delivery systems. With three patents to his name, his work primarily focuses on innovative methods for treating neurological disorders, particularly Parkinson's disease.
Latest Patents
One of Shrewsbury's most significant inventions is a dry pharmaceutical composition that facilitates the respiratory tract delivery of levodopa and a dopa decarboxylase inhibitor (DDI) for the treatment of Parkinson's disease and Parkinson syndrome. This innovative approach promises more effective delivery of these critical medications through a new dosage form. The composition combines levodopa, DDI, and at least one excipient, showcasing a novel method for dosing patients suffering from this debilitating condition.
Career Highlights
Throughout his career, Stephen Shrewsbury has been associated with leading pharmaceutical companies, including Impel Pharmaceuticals Inc. and Impel Neuropharma, Inc. His work at these organizations has been pivotal in advancing drug delivery systems tailored for neurological treatments. His inventive spirit and dedication to improving patient outcomes stand out in his accomplishments.
Collaborations
In his journey as an inventor, Shrewsbury has worked alongside notable colleagues such as John D. Hoekman and Kelsey H. Satterly. Their collaboration likely fostered an environment of innovative thinking that contributed to the successful development of his patents.
Conclusion
Stephen B. Shrewsbury exemplifies the spirit of innovation with his focus on improving treatment methodologies for Parkinson's disease. His patents not only reflect his expertise but also his commitment to enhancing patients' quality of life through advanced pharmaceutical solutions. As he continues to innovate, the impact of his work is expected to resonate in the medical field for years to come.